Voyageur Pharmaceuticals Ltd.
Voyageur Announces Advancements on its Barium & Iodine Contrast Media Projects
Voyageur Pharmaceuticals is advancing its vertically integrated strategy for barium and iodine contrast media. The company is currently completing Bankable Feasibility Studies (BFS) for its Frances Creek barium project and its iodine production initiatives, while also pursuing FDA regulatory pathways.